masteron enanthate

Drostanolone propionate, also known as dromostanolone propionate, was once promoted for the treatment of female breast cancer and was offered under the brand names Drolban, Masteril, and Masteron, among others. It is injected into the muscle.

The treatment of advanced, inoperable breast cancer in women was the main clinical indication for drostanolone propionate in both domestic and foreign markets.
For some tumor types, particularly those connected to tissues that are hormone-active, such as breast or prostate cancer, hormonal therapy is a component of complicated therapy. Breast cancer cells that express estrogen receptors are known as ER+ cancers and utilise estrogen for growth and metastasis. Antiestrogen medications, which block estrogen receptors or reduce their expression on cell membranes, may therefore be able to control the growth and development of tumors.

masteron enanthate

For these patients, drostanolone propionate was a revolution in the treatment of cancer. The risk of virilization is substantially lower than it would be with testosterone due to its reduced androgenic rate. Because of this, women, who often do not respond well to any AAS, had a significantly higher probability of surviving cancer. Drostanolone propionate can also be used as palliative care for advanced incurable cancers or for breast tumors that do not react well to other treatments. Naturally, the product’s effects are influenced by the dosage and timing of administration. High doses and prolonged administration time increase the danger of virilization.